Submit Manuscript

Journal of Biological Sciences

Year: 2005 | Volume: 5 | Issue: 1 | Page No.: 61-65
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

ABSTRACT

In higher organisms most cell types exist in a quiescent state, G0. Upon activation, cells exit from G0 and enter the proliferative phases of the cell cycle. Rapamycin-FKBP12 is a potent inhibitor of proliferation of many cell types. In BC3H1 myogenic cells, rapamycin induces differentiation while inhibiting cellular proliferation. Since terminal differentiation requires withdrawal from the cell cycle, we have studied various cell-cycle regulators, the differentiation factor myogenin and the inhibitor of differentiation, which might be involved in this process. In the present study, we show that myogenic differentiation in the presence of rapamycin is coupled with the inhibition of phosphorylation of retinoblastoma protein (pRB) and sustenance of myogenin without affecting inhibitor of differentiation (Id) protein.
PDF References Citation

Search

REFERENCES

  1. Schubert, D., A.J. Harris, C.E. Devine and S. Heinemann, 1974. Characterization of a unique muscle cell line. J. Cell Biol., 61: 398-413.
  2. Brennan, T.J., D.G. Edmonsdon and E.N. Olson, 1990. Aberrant regulation of MyoD1 contribution to the partially defective myogenic phenotype of BC3H1 cells. J. Cell Biol., 110: 929-937.
    Direct Link
  3. Strauch, A.R., J.D. Offord, R. Chalkley and P.A. Rubenstein, 1986. Characterization of actin mRNA levels during BC3H1 cell differentiation. J. Biol. Chem., 261: 849-855.
  4. Edmondson, D. and E.N. Olson, 1993. Helix-loop-helix proteins as regulators of muscle-specific transcription. J. Biol. Chem., 268: 755-788.
  5. Jayaraman, T. and A.R. Marks, 1993. Rapamycin-FKBP12 blocks proliferation, induces differentiation and inhibits cdc2 kinase activity in a myogenic cell line. J. Biol. Chem., 268: 25385-25388.
  6. Gu, W., J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi and B. Nadal-Ginard, 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell, 72: 309-324.
  7. Chen, P.L., P. Scully, J.Y. Shew, J.Y. Wang and W.H. Lee, 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell, 58: 1193-1198.
  8. Mihara, K., X.R. Cao, A. Yen, S. Chandler and B. Driscoll et al., 1989. Cell cycle dependent regulation of the phosphorylation of the human retinoblastoma gene product. Science, 246: 1300-1303.
  9. Sabourin, L.A. and M.A. Rudnicki, 2000. The molecular regulation of myogenesis. Clin. Genet., 57: 16-25.
  10. Arnold, H.H. and T. Braun, 1996. Targeted inactivation of myogenic factor genes reveals their role during mouse myogenesis: A review. Int. J. Dev. Biol., 40: 345-353.
  11. Zebedee, Z. and E. Hara, 2001. Id proteins in cell cycle control and cellular senescence. Oncogene, 20: 8317-8325.
  12. Jayaraman, T., A.M. Brillantes, A.P. Timerman, S. Fleischer and H. Erdjument-Bromage et al., 1992. FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem., 267: 9474-9477.
  13. Zacksenhaus, E., Z. Jiang, D. Chung, J.D. Marth, R.A. Phillips and B.L. Gallie, 1996. pRb controls proliferation, differentiation and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev., 10: 3051-3064.
  14. Tintignac, L.A., M.P. Leibovitch, M. Kitzmann, A. Fernandez, B. Ducommun, L. Meijer and S.A. Leibovitch, 2000. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells. Exp. Cell Res., 259: 300-307.
  15. Harbour, J.W., R.X. Luo, A. Dei-Santi, A.A. Postigo and D.C. Dean, 1999. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell, 98: 859-869.
  16. Gitig, D.M. and A. Koff, 2001. Cdk pathway: Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Mol. Biotechnol., 19: 179-188.
  17. Shu, L., X. Zhang and P.J. Houghton, 2002. Myogenic differentiation is dependent on both the kinase function and the N-terminal sequence of mammalian target of rapamycin. J. Biol. Chem., 277: 16726-16733.
  18. Cuenda, A. and P. Cohen, 1999. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J. Biol. Chem., 274: 4341-4346.
  19. Erbay, E. and J. Chen, 2001. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. J. Biol. Chem., 276: 36079-36082.
  20. Murga, M., O. Fernandez-Capetillo, S.J. Field, B. Moreno and L.R. Borlado et al., 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity, 15: 959-970.

Search

Leave a Comment

Your email address will not be published. Required fields are marked *